September 2016
Please join us in welcoming Kimberly Smith, who has taken over the Mayo Clinic Health Solutions Provider Relations responsibilities previously held by Julie Dahl. Kimberly will be your go-to resource for Provider Relations issues. To contact Kimberly, please email healthsolutionsprovserv@mayo.edu.
Kimberly is new to this role, but not new to Mayo Clinic Health Solutions. During the past 13 years, she has served on our Provider Database and Claims teams and has worked closely with Provider Relations.
The Mayo Clinic Health Solutions Customer Service Call Center will be closed from 11:45 a.m. through the end of business hours on Tuesday, October 4, 2016 for a company-wide meeting.
Member information is available 24/7 when you sign in to your Online Service Center account or through the automated voice response system when you call Customer Service. If you need to speak with a Customer Service representative, please call back on the next business day.
In August 2016, a change was made to the Mayo Clinic Formulary and the Health Tradition Formulary that limits formulary blood glucose test strips to products made by Ascensia Diabetes Care and Roche Diabetes Care. This change takes effect January 1, 2017.
Members not currently using test strips made by one of these manufacturers recently received a letter encouraging them to transition to the preferred products.
Members receiving new prescriptions for test strips are required to use the Ascensia or Roche products in order to receive coverage.
Members using insulin pumps that require specific types of test strips, as well as members with visual or cognitive conditions that require specific meters or strips may be granted exceptions to this formulary status change. The prescriber should request prior authorization for any exceptions.
If you have any questions about the test strips or meters available to members from Ascensia or Roche, please contact the manufacturers at:
If you have any questions about the formulary change, please contact Customer Service at the number listed on the member’s ID card.
Prior authorization is required for certain medications administered in an office, outpatient infusion center, or hospital setting. This list currently includes medications such as Botox and Remicade. Click here to view the list. This list and other guidance will soon be posted on our web site.
Prescribers can now use CoverMyMeds, an electronic prior authorization tool, to request prior authorization for these medications. CoverMyMeds is an easy-to-use tool that provides faster determinations – usually with 24 hours. In addition this tool offers:
To get started using CoverMyMeds, go to www.covermymeds.com and sign in to your account. You will need to register on your first visit. Then follow these steps:
Beginning July 1, 2017, Minnesota law will require every prescriber licensed by a health-related licensing board who can prescribe controlled substances to register for a user account with the Prescription Monitoring Program (PMP). This requirement applies to every pharmacist licensed in Minnesota who practices within the state. Currently, it is estimated that only 35% of prescribers have registered with the PMP.
The Minnesota PMP is run by the Minnesota Board of Pharmacy and collects information on all prescriptions filled for schedule II-V controlled substances, including gabapentin or butalbital. This registry can help prescribers and pharmacists identify patients who may be “doctor-shopping” or misusing controlled substances. In addition, this tool is useful in helping to combat opioid substance abuse while still managing pain in patients who truly need it. For more information about the Prescription Monitoring Program, the registration requirement and account creation, please visit the program’s web site.
The Electronic Funds Transfer (EFT) Authorization form is used to authorize Mayo Clinic Health Solutions to electronically transfer funds directly to your bank account. Using EFT to receive claims payments means:
For more information about signing up for EFT, please refer to the Electronic Funds Transfer section of the Provider Manual. Or, refer to the instructions on the back of the EFT form.
Review the latest updates from UCare and South Country Health Alliance.
These include:
The Centers for Disease Control and Prevention (CDC) has announced it does not support the use of the live attenuated influenza vaccine (LAIV), also known as the “nasal spray” flu vaccine, during the 2016-2017 flu season. This vaccine would be submitted with the CPT code 90672 or 90660.
South Country Health Alliance (SCHA) will be following this guideline. Effective immediately, SCHA will not be covering the flu mist for the 2016-2017 flu season for SCHA members.
Annual flu vaccination is strongly recommended. In place of the LAIV vaccine, please educate SCHA members about two other options available: inactivated influenza vaccine (IIV) and recombinant influenza vaccine (RIV).
On July 1, 2016, South Country Health Alliance (SCHA) began reimbursing providers for Medicare-covered Durable Medical Equipment (DME) based on the current published DME rural and non-rural rates.
Now that Medicare has established rural rates, DME and medical supplier payment to providers will be based on their zip code, which will determine a rural vs. non-rural rate. In cases where no rural rate has been determined, claims will continue to pay at the non-rural rate until all rural rates have been established.
For more information, please review the announcement released by the Centers for Medicare & Medicaid Services about corrections made to the July 2016 fee schedule amounts.
In 2013, the Centers for Medicare & Medicaid Services (CMS) implemented a 2% reduction (sequestration) in payments made to providers for services rendered to Medicare beneficiaries. At the same time, CMS also reduced the capitation amount paid to South Country Health Alliance (SCHA) and other Medicare Advantage health plans contracting with CMS by 2%. South Country Health Alliance, however, chose not to implement this reduction with their contracted provider network.
It was anticipated that the sequestration would sunset in 2016; however, instead, it has been continued indefinitely. Effective August 1, 2016, SCHA implemented the 2% sequestration and applied the reduction to SCHA's Medicare fee schedule, applicable to all Medicare eligible, covered services. Questions may be directed to SCHA Provider Services at 1-800-995-4543.
If a significant, separately identifiable Evaluation and Management (E&M) service is provided at the time of the Child and Teen Checkup (C&TC) screening, that E&M code must be billed with the modifier 25. Documentation in the health record must support key components of billed E&M services.
Please follow Current Procedural Terminology (CPT) instructions for appropriate coding. The National Correct Coding Initiative (NCCI) rules state that a vaccine administration and E&M code cannot be billed on the same day, by the same provider, unless a “significant, separately identifiable service by the same physician was provided on the same day.”
Please visit the Minnesota Department of Human Services web site for more information on C&TC requirements.
As of October 31, 2016, UCare will no longer use Beacon Health Strategies LLC (Beacon) to perform utilization review of behavioral health prior authorization requests. UCare has decided to bring behavioral health utilization management functions in-house beginning in mid-October, 2016.
What Does This Mean For UCare Providers?
UCare offers a Complex Case Management program designed to provide support and assistance to members who have had a major health event or require extensive use of resource, or who need assistance with coordinating their care. UCare identifies members for enrollment in the program using predictive modeling tools. In addition, UCare welcomes individual member referrals from providers. Other referral sources may include: Disease Management Program, Discharge Planner, and member or caregiver.
Complex Case Management referrals are screened for program eligibility and assigned to complex case managers as received. UCare accepts all referrals for screening for the Complex Case Management program. Participation in this program is voluntary and free for eligible UCare for Seniors and UCare Choices (Exchange) members.
To refer a member to the Complex Case Management program, please complete the referral form available on the UCare web site. Referrals and related documentation should be faxed to 612-884-2284. For more information, or if you have any questions about this program, please call 612-676-6538.